|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,779.50 JPY | 0.00% |
|
-2.03% | +5.48% |
| 02-17 | Sekisui Chemical Co., Ltd. Announces Board Changes | CI |
| 02-17 | SEKISUI CHEMICAL CO., LTD. Announces President Changes, Effective March 1, 2026 | CI |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.73 | 4.73 | 4.72 | 4.62 | 5.08 | |||||
Return on Total Capital | 5.31 | 6.7 | 6.83 | 6.58 | 7.15 | |||||
Return On Equity % | 6.51 | 5.55 | 9.86 | 10.18 | 10.16 | |||||
Return on Common Equity | 6.51 | 5.53 | 10.04 | 10.41 | 10.24 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 31.27 | 30.74 | 30.36 | 31.21 | 32.41 | |||||
SG&A Margin | 20.17 | 18.64 | 18.53 | 19.07 | 19.4 | |||||
EBITDA Margin % | 11.04 | 11.88 | 11.6 | 11.7 | 12.46 | |||||
EBITA Margin % | 6.79 | 7.92 | 7.65 | 7.63 | 8.43 | |||||
EBIT Margin % | 6.37 | 7.68 | 7.38 | 7.51 | 8.32 | |||||
Income From Continuing Operations Margin % | 4.1 | 3.35 | 5.7 | 6.29 | 6.48 | |||||
Net Income Margin % | 3.93 | 3.2 | 5.57 | 6.2 | 6.31 | |||||
Net Avail. For Common Margin % | 3.93 | 3.2 | 5.57 | 6.2 | 6.31 | |||||
Normalized Net Income Margin | 3.54 | 5.09 | 5.16 | 5.2 | 5.27 | |||||
Levered Free Cash Flow Margin | 0.29 | 5.39 | -0.24 | 2.58 | 3.19 | |||||
Unlevered Free Cash Flow Margin | 0.34 | 5.43 | -0.2 | 2.64 | 3.24 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.94 | 0.99 | 1.02 | 0.98 | 0.98 | |||||
Fixed Assets Turnover | 3.07 | 3.23 | 3.35 | 3.26 | 3.26 | |||||
Receivables Turnover (Average Receivables) | 6.17 | 6.54 | 6.62 | 6.25 | 6.23 | |||||
Inventory Turnover (Average Inventory) | 3.3 | 3.44 | 3.26 | 2.95 | 2.87 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.79 | 1.85 | 1.9 | 1.99 | 2.07 | |||||
Quick Ratio | 0.91 | 1 | 0.89 | 1.02 | 1.02 | |||||
Operating Cash Flow to Current Liabilities | 0.27 | 0.32 | 0.22 | 0.31 | 0.35 | |||||
Days Sales Outstanding (Average Receivables) | 59.11 | 55.78 | 55.12 | 58.55 | 58.54 | |||||
Days Outstanding Inventory (Average Inventory) | 110.6 | 106.21 | 111.92 | 123.86 | 127.34 | |||||
Average Days Payable Outstanding | 62.18 | 56.72 | 55.21 | 54.42 | 50.58 | |||||
Cash Conversion Cycle (Average Days) | 107.53 | 105.27 | 111.83 | 127.99 | 135.31 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 19.9 | 17.44 | 16.44 | 14.71 | 13.27 | |||||
Total Debt / Total Capital | 16.6 | 14.85 | 14.12 | 12.82 | 11.71 | |||||
LT Debt/Equity | 18.18 | 16.12 | 15.25 | 12.63 | 12.34 | |||||
Long-Term Debt / Total Capital | 15.17 | 13.72 | 13.1 | 11.01 | 10.89 | |||||
Total Liabilities / Total Assets | 39.63 | 41.38 | 40.35 | 37.96 | 37.23 | |||||
EBIT / Interest Expense | 78.17 | 114.83 | 105.24 | 85.58 | 104 | |||||
EBITDA / Interest Expense | 135.48 | 177.76 | 165.41 | 133.34 | 155.79 | |||||
(EBITDA - Capex) / Interest Expense | 71.18 | 129.96 | 114.12 | 91.57 | 99.81 | |||||
Total Debt / EBITDA | 1.18 | 0.89 | 0.84 | 0.82 | 0.69 | |||||
Net Debt / EBITDA | 0.43 | -0.16 | 0.13 | -0.12 | -0.2 | |||||
Total Debt / (EBITDA - Capex) | 2.25 | 1.22 | 1.21 | 1.2 | 1.07 | |||||
Net Debt / (EBITDA - Capex) | 0.83 | -0.22 | 0.19 | -0.18 | -0.31 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -6.44 | 9.6 | 7.3 | 1.13 | 3.28 | |||||
Gross Profit, 1 Yr. Growth % | -8.91 | 7.74 | 5.98 | 3.96 | 7.24 | |||||
EBITDA, 1 Yr. Growth % | -12.45 | 17.95 | 4.72 | 2.08 | 9.95 | |||||
EBITA, 1 Yr. Growth % | -21.21 | 27.82 | 3.71 | 0.84 | 14.05 | |||||
EBIT, 1 Yr. Growth % | -23.32 | 32.06 | 3.13 | 2.98 | 14.36 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -29.01 | -10.44 | 82.58 | 11.71 | 6.39 | |||||
Net Income, 1 Yr. Growth % | -29.5 | -10.78 | 86.86 | 12.51 | 5.13 | |||||
Normalized Net Income, 1 Yr. Growth % | -28.5 | 57.48 | 8.75 | 1.96 | 4.64 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -28.32 | -9.52 | 91.41 | 15.26 | 6.78 | |||||
Accounts Receivable, 1 Yr. Growth % | -1.9 | 8.87 | 3.43 | 10.68 | -2.89 | |||||
Inventory, 1 Yr. Growth % | 2.63 | 9.39 | 17.62 | 3.99 | 5.23 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.19 | 3.94 | 3.32 | 4 | 2.9 | |||||
Total Assets, 1 Yr. Growth % | 4.34 | 4.24 | 2.44 | 7.74 | 0.57 | |||||
Tangible Book Value, 1 Yr. Growth % | 12.02 | 10.27 | 4.16 | 12.11 | 2.04 | |||||
Common Equity, 1 Yr. Growth % | 9.47 | 1.13 | 4.5 | 12.38 | 1.9 | |||||
Cash From Operations, 1 Yr. Growth % | -18.76 | 39.53 | -31.88 | 49.05 | 11.82 | |||||
Capital Expenditures, 1 Yr. Growth % | 5.08 | -33.17 | 20.75 | 3.12 | 26.12 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -91.9 | 1.93K | -104.84 | -1.17K | 27.71 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -90.59 | 1.64K | -103.93 | -1.44K | 27.01 | |||||
Dividend Per Share, 1 Yr. Growth % | 2.17 | 4.26 | 20.41 | 25.42 | 6.76 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -3.84 | 1.26 | 8.44 | 4.17 | 2.2 | |||||
Gross Profit, 2 Yr. CAGR % | -5.26 | -0.94 | 6.86 | 4.97 | 5.59 | |||||
EBITDA, 2 Yr. CAGR % | -7.84 | 1.62 | 11.14 | 3.39 | 5.94 | |||||
EBITA, 2 Yr. CAGR % | -14.68 | 0.36 | 15.14 | 2.27 | 7.24 | |||||
EBIT, 2 Yr. CAGR % | -16.13 | 0.63 | 16.71 | 3.06 | 8.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -20.5 | -20.26 | 27.88 | 42.81 | 9.02 | |||||
Net Income, 2 Yr. CAGR % | -20.72 | -20.69 | 29.12 | 45 | 8.76 | |||||
Normalized Net Income, 2 Yr. CAGR % | -18.13 | 6.11 | 30.86 | 5.3 | 3.29 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -19.44 | -19.47 | 31.6 | 48.53 | 10.94 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.44 | 3.34 | 6.11 | 6.99 | 3.67 | |||||
Inventory, 2 Yr. CAGR % | 7.7 | 5.96 | 13.43 | 10.59 | 4.6 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 6.56 | 4.07 | 3.63 | 3.66 | 3.45 | |||||
Total Assets, 2 Yr. CAGR % | 6 | 4.29 | 3.33 | 5.06 | 4.1 | |||||
Tangible Book Value, 2 Yr. CAGR % | 1.15 | 11.14 | 7.17 | 8.06 | 6.96 | |||||
Common Equity, 2 Yr. CAGR % | 4.81 | 5.22 | 2.81 | 8.37 | 7.01 | |||||
Cash From Operations, 2 Yr. CAGR % | -6.01 | 6.47 | -2.51 | 0.76 | 29.1 | |||||
Capital Expenditures, 2 Yr. CAGR % | -4.01 | -16.2 | -10.17 | 11.59 | 14.04 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -70.47 | 28.3 | -0.86 | -27.94 | 270.29 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -68.12 | 28.07 | -17.2 | -27.45 | 312.16 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.35 | 3.21 | 12.04 | 22.89 | 15.71 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -1.56 | 0.44 | 3.24 | 5.95 | 3.87 | |||||
Gross Profit, 3 Yr. CAGR % | -3.01 | -1.11 | 1.32 | 5.88 | 5.72 | |||||
EBITDA, 3 Yr. CAGR % | -5.37 | 0.06 | 2.64 | 8.03 | 5.53 | |||||
EBITA, 3 Yr. CAGR % | -10.97 | -2.38 | 1.46 | 10.16 | 6.05 | |||||
EBIT, 3 Yr. CAGR % | -12.14 | -2.43 | 1.46 | 11.94 | 6.69 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -13.43 | -17.28 | 5.1 | 22.24 | 29.46 | |||||
Net Income, 3 Yr. CAGR % | -13.17 | -17.53 | 5.53 | 23.33 | 30.26 | |||||
Normalized Net Income, 3 Yr. CAGR % | -12.28 | 1.82 | 6.98 | 20.42 | 5.08 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -11.71 | -16.26 | 7.48 | 25.91 | 33.06 | |||||
Accounts Receivable, 3 Yr. CAGR % | -2.29 | -0.2 | 3.37 | 7.62 | 3.59 | |||||
Inventory, 3 Yr. CAGR % | 9.35 | 8.26 | 9.71 | 10.19 | 8.77 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 7.9 | 5.68 | 3.82 | 3.75 | 3.41 | |||||
Total Assets, 3 Yr. CAGR % | 4.8 | 5.41 | 3.67 | 4.78 | 3.54 | |||||
Tangible Book Value, 3 Yr. CAGR % | 1.98 | 4.11 | 8.77 | 8.79 | 6.02 | |||||
Common Equity, 3 Yr. CAGR % | 4.29 | 3.57 | 4.98 | 5.9 | 6.17 | |||||
Cash From Operations, 3 Yr. CAGR % | -2.92 | 7.22 | -8.26 | 12.31 | 4.32 | |||||
Capital Expenditures, 3 Yr. CAGR % | 6.74 | -14.92 | -5.35 | -5.94 | 16.24 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -41.89 | 21.02 | -56.98 | 119.34 | -12.79 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -39.1 | 20.99 | -59.89 | 109.32 | -12.57 | |||||
Dividend Per Share, 3 Yr. CAGR % | 6.42 | 3.65 | 8.65 | 16.34 | 17.26 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.74 | 1.67 | 2.33 | 1.92 | 2.82 | |||||
Gross Profit, 5 Yr. CAGR % | -0.91 | 0.14 | 0.82 | 1.28 | 3.01 | |||||
EBITDA, 5 Yr. CAGR % | -1.64 | 0.61 | 0.91 | 1.38 | 3.95 | |||||
EBITA, 5 Yr. CAGR % | -4.85 | -1.45 | -1.33 | -0.55 | 3.74 | |||||
EBIT, 5 Yr. CAGR % | -5.61 | -1.63 | -1.57 | -0.27 | 4.23 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -5.6 | -8.94 | 1.19 | 2.91 | 6.65 | |||||
Net Income, 5 Yr. CAGR % | -6.02 | -9.44 | 1.77 | 3.35 | 6.81 | |||||
Normalized Net Income, 5 Yr. CAGR % | -5.51 | 0.97 | 2.94 | 3.2 | 5.49 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -4.36 | -7.97 | 3.57 | 5.31 | 8.85 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.56 | 2.52 | 0.99 | 2.62 | 3.49 | |||||
Inventory, 5 Yr. CAGR % | 8.14 | 9.69 | 10.97 | 9.19 | 7.64 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.41 | 6.89 | 6.17 | 4.87 | 3.67 | |||||
Total Assets, 5 Yr. CAGR % | 4.21 | 4.91 | 4.21 | 5.27 | 3.84 | |||||
Tangible Book Value, 5 Yr. CAGR % | 3.48 | 4.24 | 4.02 | 5.67 | 8.04 | |||||
Common Equity, 5 Yr. CAGR % | 4.96 | 4.18 | 3.7 | 5.46 | 5.79 | |||||
Cash From Operations, 5 Yr. CAGR % | 1.06 | -0.6 | -2.76 | 4.59 | 5.17 | |||||
Capital Expenditures, 5 Yr. CAGR % | 7.01 | 0.98 | -0.38 | -5.17 | 1.98 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -38.22 | 0.2 | -28.04 | -1.64 | 1.77 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -36.46 | 0.23 | -31.14 | -1.39 | 1.86 | |||||
Dividend Per Share, 5 Yr. CAGR % | 9.39 | 7.58 | 8.63 | 10.96 | 11.42 |
- Stock Market
- Equities
- 4204 Stock
- Financials Sekisui Chemical Co., Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















